Trials / Unknown
UnknownNCT03664050
Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary
Laparoscopic Ovarian Drilling Versus Letrozole In Clomiphene Citrate Resistant Polycystic Ovary: A Randomized Controlled Trial
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 90 (estimated)
- Sponsor
- Ain Shams University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this work is to compare the clinical outcomes of letrozole with laparoscopic ovarian drilling (LOD) in patients with clomiphene-citrate-resistant polycystic ovary syndrome (PCOS).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | group A 2.5 mg letrozole oral tablets | 2.5 mg letrozole oral tablets will be administered on the 2nd-3rd day of menses and then every day for 5 days. Treatment will be repeated for up to three cycles if the patient failed to conceive. |
| PROCEDURE | laparoscopic ovarian drilling | Bilateral laparoscopic ovarian drilling, each ovary will be cauterized at 4 points, each for 4 sec at 40 W, at a depth of 7-8 mm and a diameter of 3-5 mm, using a monopolar electrosurgical needle according to the size of each ovary. |
Timeline
- Start date
- 2018-01-01
- Primary completion
- 2018-12-01
- Completion
- 2018-12-01
- First posted
- 2018-09-10
- Last updated
- 2018-09-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03664050. Inclusion in this directory is not an endorsement.